Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Nutriband Inc. NTRB

Set alert

Price alert · NTRB

All alert types
6.41 USD +0.11 +1.75%

At close · Nov 2

6.29 -0.12 -1.87%

After hours · Nov 2, 4:00 PM ET

Bid
6.15 × 2
Ask
6.43 × 2
6.13 Day range 6.50
2.80 52-week range 9.19
YTD
+41.19%
1 year
-4.75%
Open
6.30
Prev close
6.30
Mkt cap
77.92M
Vol
14.74K
Avg vol
68.68K
EPS
-0.54
P/E
0.00
Div yield
0.00%
More statistics
Low
6.13
High
6.50
Forward P/E
-17.30
Beta
0.42
Short ratio
1.53
Inst. own
2.38%
Dividend
0.00
Ex-div date
50-d avg
5.30
200-d avg
5.09
1y target
0.00

YTD chart

Chart tools
Interval
1m5m15m30m

Signals (38)
NameDateAgo
SMA: BullishNov 2, 202618 hours ago
MACD: Buy SignalNov 2, 202618 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 28, 20265 days ago
SMA: BearishOct 22, 20261 week ago
SMA: BullishOct 21, 20261 week ago
SMA: BearishOct 20, 20261 week ago
MACD: Sell SignalSep 30, 20261 month ago
RSI: OverboughtSep 24, 20261 month ago
RSI: OverboughtSep 3, 20262 months ago
RSI: OverboughtAug 27, 20262 months ago
SMA: BullishAug 21, 20262 months ago
RSI: OverboughtAug 20, 20262 months ago
SMA: BullishAug 13, 20262 months ago
SMA: BearishAug 12, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
MACD: Sell SignalJul 31, 20263 months ago
MACD: Buy SignalJun 30, 20264 months ago
RSI: OversoldJun 18, 20264 months ago
MACD: Sell SignalJun 16, 20264 months ago

Newest 20 of 38.

Key statistics

Financials
Market cap
44.20M
Enterprise value
44.16M
Trailing P/E
0.00
Forward P/E
-17.30
PEG ratio
0.00
Price / sales
21.92
Price / book
5.47
EPS (TTM)
-0.71
Beta
0.42
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
2.02M
Revenue growth
-14.30%
Free cash flow
-1.55M
Total cash
8.35M
Total debt
527.92K
Return on equity
-60.41%
Shares outstanding
11.11M
Short % of float
1.00%
50-day average
5.30
200-day average
5.09

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NTRB Revenue — quarterly 437.51K
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
NTRB Net income — quarterly -880.56K
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026
NTRB EPS — quarterly -0.07
2023-Q3 20222023-Q4 20222024-Q1 20232024-Q2 20232024-Q3 20232024-Q4 20232025-Q1 20242025-Q2 20242025-Q3 20242025-Q4 20242026-Q1 20252026-Q2 20252026-Q3 20252026-Q4 20252027-Q1 20262027-Q2 2026

Earnings

NTRB recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Dec 3, 2024Oct 1, 20240.00-0.12——
Sep 3, 2024Jul 1, 20240.00-0.12——
May 31, 2024Apr 1, 20240.00-0.21——
Apr 30, 2024Jan 1, 20240.00-0.16——
Dec 12, 2023Oct 1, 20230.00-0.22——
Sep 11, 2023Jul 1, 20230.00-0.11——

Upgrades / downgrades

NTRB analyst upgrades and downgrades
DateFirmActionFromTo
Jul 26, 2022Small Cap Consumer Researchmain—Buy

About Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
nutriband.com

News

All news

Your note

Sign in to keep a note on NTRB — it syncs with the Stock Master app.

Insider holders

NTRB insider holders
InsiderRelationLatest transactionDateShares held
MELNIK SERGUEIPresidentStock GiftMar 5, 2023827,999

Institution ownership

NTRB institution ownership
Holder% heldSharesValueReported
Vanguard Group Inc1.86%118,063469.89KSep 29, 2024
Geode Capital Management, LLC0.91%58,063231.09KSep 29, 2024
UBS Group AG0.32%20,35281.00KSep 29, 2024
Avantax Advisory Services, Inc.0.29%18,67874.34KSep 29, 2024
State Street Corporation0.27%17,26668.72KSep 29, 2024
Farther Finance Advisors, Llc0.25%16,01463.73KSep 29, 2024

Fund ownership

NTRB fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.13%71,575284.87KSep 29, 2024
Vanguard Extended Market Index Fund0.69%43,788174.28KSep 29, 2024
Fidelity Extended Market Index Fund0.46%29,333116.75KOct 30, 2024
Fidelity Total Market Index Fund0.16%9,88239.33KOct 30, 2024
Fidelity Series Total Market Index Fund0.11%7,26028.89KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.11%6,71826.74KOct 30, 2024

Splits

NTRB stock splits
DateRatio
Aug 15, 202213:6
Aug 12, 2022116.667:100
Jul 24, 20191:4